The biopharmaceutical industry has been undergoing change for a number of years and that change is accelerating.Â Larger pharmaceutical companies are acquiring smaller ones, companies are merging, laboratories are being closed, and the number of scientists performing research in the pharmaceutical industry is declining.Â Overall, commercial industry, including the biotechnology industry, is becoming more interested in the benefits of collaboration with research institutions.
Universities are also changing their view of relationships with industry.Â Shrinking federal budgets are causing universities to look at other sources of revenue, including collaborations with industry.Â Federal and state governments are also looking closely at the benefits of sponsoring university research, and in particular are seeking to accelerate commercialization of university discoveries not only to obtain the benefit of invested research dollars, but also for economic development and job growth.Â Universities, and in particular university technology transfer offices, must understand these changes and adapt to them.Â
This paper discusses the university/industry relationships, and the particular issues important to universities which shape that interface.Â
Littman, Bruce H. and Marincola, Francesco M., (2011) Editorial: Create A Translational Medicine Knowledge Repository. Journal of Translational Medicine 9:56
The New Economy (2010) Big Pharmaâ€™s Stalled R & D Machine, 16 June,
http://www.theneweconomy.com/science-and-technology/pharmaceuticals/542-big-pharmas-stalled-rd-machine/, accessed October 31, 2011.
Kling, Jim (2011) Biotechs Follow Big Pharma Lead Back Into Academia. Nature Biotechnology 29: 555â€“556
Rev. Proc. 2007 â€“ 47.
Unless specified by prior arrangement, the author agrees to the following terms and assurances:
- For myself and on behalf of the other authors listed on this work, I assign to thinkBiotech LLC the copyright* in the contribution for the full term throughout the world.
- I/we further give to the following assurances
- I am the sole author of the contribution, or, if not, I have the written authority of the other authors to transfer the copyright* to thinkBiotech LLC and give these warranties;
- I and (where appropriate) the other authors are entitled to transfer the copyright to thinkBiotech LLC and no one else would be entitled to prevent us from publishing the contribution;
- To the best of my/our knowledge, all the facts in the contribution are true and accurate;
- The content of the contribution is entirely original to me (and where appropriate to the other authors) or, if not, the written permission of the owner of the copyright in any material copied from elsewhere has been obtained for all media (all such permissions to be attached to the contribution as supplementary files);
- Nothing in the contribution is obscene or libellous;
- Nothing in the contribution infringes any duty of confidentiality which I/or the other authors may owe to anyone else.
- I and/or the other authors have obtained the appropriate clearances from my/our employer(s) or other concerned institution(s).